Home › Funds › EQT Fund Management S.a r.l. › OCS

EQT Fund Management S.a r.l. position in OCS

Oculis Holding AG · Health Care

EQT Fund Management S.a r.l. reported holding 6,950,294 shares of OCS (Oculis Holding AG) in its Q3 2026 13F filing — a position valued at US$64.9M, representing 6.85% of its reported portfolio and ranking #3 among its reported holdings. EQT Fund Management S.a r.l. has disclosed OCS holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)6.95M sh
Reported value held$64.92M
Portfolio Weight6.85%
First reportedQ3 2025
Last changeHold
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How EQT Fund Management S.a r.l.'s OCS position evolved

EQT Fund Management S.a r.l. first disclosed a stake in OCS in Q3 2025 at 5,900,294 shares (US$103.7M). The position peaked in Q1 2026 at 5,900,294 shares, worth US$156.9M. Across 5 filings, EQT Fund Management S.a r.l. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 6,950,294 shares valued at US$64.9M.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 5.90M $103.73M New
Q4 2025 5.90M $117.83M Hold
Q1 2026 5.90M $156.89M Hold
Q2 2026 6.95M $96.40M Add
Q3 2026 6.95M $64.92M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About OCS and 13F data

OCS (Oculis Holding AG) is a Health Care company. 64 other funds we track also report a position in OCS — the largest reported positions include Gildi - lifeyrissjodur (US$64.3M), Pivotal bioVenture Partners Investment Advisor LLC (US$20.9M), Saturn V Capital Management LP (US$9.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding OCS

All OCS fund holders →

FAQ

How long has EQT Fund Management S.a r.l. held OCS?

EQT Fund Management S.a r.l. has disclosed OCS holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is EQT Fund Management S.a r.l.'s current position in OCS?

As of Q3 2026, EQT Fund Management S.a r.l. holds 6.95M shares of OCS (Oculis Holding AG), valued at $64.92M, representing 6.85% of its reported portfolio and ranking #3.

Has EQT Fund Management S.a r.l. been buying or selling OCS?

In the latest 13F filing (Q3 2026), EQT Fund Management S.a r.l. held unchanged its position in OCS. The position peaked in Q1 2026 at 5.90M shares.

Which other funds hold OCS?

Other major institutional holders of OCS include Gildi - lifeyrissjodur, Pivotal bioVenture Partners Investment Advisor LLC, Saturn V Capital Management LP, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.